Accéder au contenu
Merck

In vitro insulin release from thermosensitive chitosan hydrogel.

AAPS PharmSciTech (2012-03-07)
Elham Khodaverdi, Mohsen Tafaghodi, Fariba Ganji, Khalil Abnoos, Hanie Naghizadeh
RÉSUMÉ

Recently, great attention has been paid to in situ gel-forming chitosan/glycerol-phosphate (chitosan/Gp) solution due to their good biodegradability and thermosensitivity. This in situ gel-forming system is injectable fluid that can be introduced into the body in a minimally invasive manner prior to solidifying within the desired tissue. At the present study, insulin release from chitosan/Gp solution has been investigated. Insulin in different concentrations was loaded in two formulations of chitosan/Gp solution and in vitro drug release was studied over a period of 3 weeks. Results indicated that the release of insulin from chitosan/Gp gel decreases by increasing in Gp salt and initial insulin concentration. Stability of released insulin was investigated by 8-anilino-1-naphthalenesulfonate probe. Results proved that insulin have been released in its native form. Because of simple preparation and administration, prolonged release of insulin and stability of released insulin, this in situ gel-forming system could be used as a controlled release delivery system for insulin.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Glycerol phosphate calcium salt, >98% (TLC)